Courtesy Photo | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.15.2018
When Ebola virus disease (EVD) reared its head in May in the Congo, the world was armed with the rVSV-ZEBOV vaccine thanks to interagency collaboration efforts by the Defense Threat Reduction Agency’s Chemical and Biological Technologies Department....
Courtesy Photo | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 10.15.2018
A number of DNA vaccine delivery devices are in commercial development which have the potential to overcome these logistical burdens. Several of them will be evaluated by medical personnel at the Delivery of Nucleic Acid Vaccines (DONAVAX) User Feedback Event (UFE). During the UFE, military medical personnel will have the opportunity to survey a range of next-generation DNA delivery devices on......
Courtesy Photo | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 07.17.2018
Official DTRA graphics
Courtesy Photo | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 12.14.2016
Current BSVE applications.
